Executive leader with over a decade of experience leading worldwide pre-clinical and clinical programs in oncology and immune-oncology. Heading multi-disciplinary teams and managing multi-million-dollar budgets in private and publicly traded companies. Prior to joining KAHR, served as Chief Development Officer at Cellect Biotechnology (APOP) and as Senior Director of Oncology at BioLineRx (BLRX). Prior to that held R&D positions at Genentech, a leading biotechnology company, member of the Roche Group.